Bishop JF - Search Results

1

A dose finding study of prochlorperazine as an antiemetic for cancer chemotherapy.

Olver IN, Webster LK, Bishop JF, Clarke J, Hillcoat BL. Olver IN, et al. Among authors: bishop jf. Eur J Cancer Clin Oncol. 1989 Oct;25(10):1457-61. doi: 10.1016/0277-5379(89)90104-1. Eur J Cancer Clin Oncol. 1989. PMID: 2591437

2

Phase I clinical and pharmacokinetics study of high-dose toremifene in postmenopausal patients with advanced breast cancer.

Bishop J, Murray R, Webster L, Pitt P, Stokes K, Fennessy A, Olver I, Leber G. Bishop J, et al. Cancer Chemother Pharmacol. 1992;30(3):174-8. doi: 10.1007/BF00686307. Cancer Chemother Pharmacol. 1992. PMID: 1385761 Clinical Trial.

3

A randomized trial of cisplatin versus cisplatin plus methotrexate in advanced cancer of the urothelial tract.

Hillcoat BL, Raghavan D, Matthews J, Kefford R, Yuen K, Woods R, Olver I, Bishop J, Pearson B, Coorey G, et al. Hillcoat BL, et al. J Clin Oncol. 1989 Jun;7(6):706-9. doi: 10.1200/JCO.1989.7.6.706. J Clin Oncol. 1989. PMID: 2654329 Clinical Trial.

4

Lorazepam: a randomized, double-blind, crossover study of a new antiemetic in patients receiving cytotoxic chemotherapy and prochlorperazine.

Bishop JF, Olver IN, Wolf MM, Matthews JP, Long M, Bingham J, Hillcoat BL, Cooper IA. Bishop JF, et al. J Clin Oncol. 1984 Jun;2(6):691-5. doi: 10.1200/JCO.1984.2.6.691. J Clin Oncol. 1984. PMID: 6374058 Clinical Trial.

5

A phase I and pharmacokinetics study of prolonged ambulatory-infusion carboplatin.

Olver IN, Webster LK, Millward MJ, Stokes KH, Bishop JF. Olver IN, et al. Among authors: bishop jf. Cancer Chemother Pharmacol. 1995;37(1-2):79-85. doi: 10.1007/BF00685632. Cancer Chemother Pharmacol. 1995. PMID: 7497601 Clinical Trial.

6

A randomised double blind crossover study of domperidone and prochlorperazine suppositories for controlling emesis in outpatients receiving chemotherapy.

Olver IN, Laidlaw CR, Matthews JP, Bishop JF, Hayes AM, Wolf M, Toner GC. Olver IN, et al. Among authors: bishop jf. Eur J Cancer. 1994;30A(4):426-9. doi: 10.1016/0959-8049(94)90411-1. Eur J Cancer. 1994. PMID: 8018396 Clinical Trial.

7

Phase I trial of docetaxel and cisplatin in previously untreated patients with advanced non-small-cell lung cancer.

Millward MJ, Zalcberg J, Bishop JF, Webster LK, Zimet A, Rischin D, Toner GC, Laird J, Cosolo W, Urch M, Bruno R, Loret C, James R, Blanc C. Millward MJ, et al. Among authors: bishop jf. J Clin Oncol. 1997 Feb;15(2):750-8. doi: 10.1200/JCO.1997.15.2.750. J Clin Oncol. 1997. PMID: 9053501 Clinical Trial.

8

Phase I dose intensification study of 2-weekly epirubicin with GM-CSF in advanced cancer.

Michael M, Toner GC, Olver IN, Fenessy A, Bishop JF. Michael M, et al. Among authors: bishop jf. Am J Clin Oncol. 1997 Jun;20(3):259-62. doi: 10.1097/00000421-199706000-00010. Am J Clin Oncol. 1997. PMID: 9167749 Clinical Trial.

9

Phase I trial of cremophor EL with bolus doxorubicin.

Millward MJ, Webster LK, Rischin D, Stokes KH, Toner GC, Bishop JF, Olver IN, Linahan BM, Linsenmeyer ME, Woodcock DM. Millward MJ, et al. Among authors: bishop jf. Clin Cancer Res. 1998 Oct;4(10):2321-9. Clin Cancer Res. 1998. PMID: 9796961 Clinical Trial.

10

A pharmacokinetic and phase II study of gallium nitrate in patients with non-small cell lung cancer.

Webster LK, Olver IN, Stokes KH, Sephton RG, Hillcoat BL, Bishop JF. Webster LK, et al. Among authors: bishop jf. Cancer Chemother Pharmacol. 2000;45(1):55-8. doi: 10.1007/PL00006743. Cancer Chemother Pharmacol. 2000. PMID: 10647502 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

181 results

Search Page